15/09/2026
One of cancer’s greatest challenges is not only its ability to grow, but also its ability to evade the body’s immune defenses. This can allow cancer cells to remain hidden from the very system designed to protect us.
The Momotaro Vaccine takes a different approach. As an oncolytic immunotherapy, it is designed to interact selectively with cancer cells while promoting immune recognition. Its approach includes stimulating interferon signaling and supporting the activity of Natural Killer cells and cytotoxic T-cells.
Curious about the science behind Momotaro?
Contact 📩 [email protected] to learn more.